0001964306-24-000250.txt : 20240611 0001964306-24-000250.hdr.sgml : 20240611 20240611165042 ACCESSION NUMBER: 0001964306-24-000250 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Mineralys Therapeutics, Inc. CENTRAL INDEX KEY: 0001933414 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-41614 FILM NUMBER: 241036443 BUSINESS ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: (888) 378-6240 MAIL ADDRESS: STREET 1: 150 N. RADNOR CHESTER ROAD STREET 2: SUITE F200 CITY: RADNOR STATE: PA ZIP: 19087 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Levy Adam Scott CENTRAL INDEX KEY: 0001693134 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O MIRAGEN THERAPEUTICS, INC. STREET 2: 6200 LOOKOUT ROAD, #100 CITY: BOULDER STATE: CO ZIP: 80301 144 1 primary_doc.xml 144 0001693134 XXXXXXXX LIVE 0001933414 Mineralys Therapeutics, Inc. 001-41614 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240 Levy Adam Scott Officer Common Stock Merrill Lynch

225 Liberty St Floor 37 New York NY 10281

96815 1252720.41 49648540 06/11/2024 NASDAQ Common Stock 06/10/2024 Vesting of restricted stock unit award Mineralys Therapeutics, Inc. N 96815 06/10/2024 Granted as part of issuer equity compensation plan Y 06/11/2024 Adam Levy